巴西婴儿接种BCG Moreau与BCG Russia菌株后细胞因子产生及临床反应的比较
该病例系列纳入15名健康婴儿,在出生后7天内接种BCG Moreau或BCG Russia,随访12周以上,比较全血培养上清细胞因子水平及卡痕形成。两种菌株均诱导相似Th1特征,但BCG Russia诱导更明显的细胞因子产生;BCG Russia接种后卡痕更轻且更不频繁。
要点
- 两种BCG菌株均诱导相似Th1特征,但BCG Russia诱导更明显的细胞因子产生。
- BCG Russia接种后卡痕更轻且更不频繁,但两组均有卡痕记录。
- 两种菌株总体耐受良好,卡痕演变符合预期。
核心结论
- 两种BCG菌株诱导相似Th1特征,BCG Russia诱导更明显的细胞因子产生;两种菌株总体耐受良好,卡痕演变符合预期。
研究设计与样本
- 病例系列纳入15名健康婴儿,出生后7天内接种BCG Moreau或BCG Russia之一,随访12周或更长。
- 接种前后测量全血培养上清细胞因子水平,培养前分别用BCG菌株、热灭活结核分枝杆菌H37Rv或无刺激体外刺激。
- 记录BCG卡痕形成。
主要发现
- 接种BCG Moreau的婴儿基础IL-2、IL-10和IL-4产生增加,而接种BCG Russia者未见差异。
- 两种菌株均诱导较高水平IL-2和IFN-γ,但BCG Russia还可见IL-6、TNF和IL-10产生升高。
- 对热灭活结核分枝杆菌H37Rv未见特异性反应,例外是BCG Moreau接种后IL-2升高。
- 两组均有卡痕记录,但BCG Russia接种后卡痕更轻且更不频繁。
临床怎么用
- 提示两种BCG菌株在婴儿中均具免疫原性且耐受良好,卡痕差异需在监测中关注。
局限性
- 原文未报告样本量以外的设计细节、统计比较方法及P值,病例系列设计限制因果推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: BCG is the only licensed vaccine against tuberculosis (TB) and, in Brazil, comprises part of the recommended vaccine schedule within the first month of life. Due to a local manufacturing shortage of BCG Moreau, BCG Russia was introduced in 2017 by the Brazilian Ministry of Health. OBJECTIVE: To evaluate differences in immune responses induced by BCG Moreau and BCG Russia in infants, in addition to scar formation. METHODS: The present case series involved 15 healthy infants who were vaccinated within the first seven days of life with one of two strains of BCG, then followed for 12 weeks or longer. Cytokine levels were measured before and after vaccination in whole blood culture supernatants previously stimulated in vitro with either BCG strain, heat-killed M. tuberculosis H37Rv or in the absence of stimulation. BCG scarring was also documented. RESULTS: Infants vaccinated with BCG Moreau exhibited increased background IL-2, IL-10 and IL-4 production, yet no differences were found in those vaccinated with BCG Russia. Although both strains induced higher levels of IL-2 and IFN-γ, elevated IL-6, TNF and IL-10 production was also seen in response to BCG Russia. In contrast, no specific responses were observed against heat-killed M. tuberculosis H37Rv, with the exception of increased IL-2 following BCG Moreau vaccination. Although documented in both groups, scarring was milder and less frequent following BCG Russia vaccination. CONCLUSIONS: Similar Th1 profiles were found following immunization with either type of BCG vaccine evaluated herein, with more pronounced cytokine production detected in response to the Russia strain. Overall, vaccination was well-tolerated and scarring evolved as expected for both BCG strains.
引用
- Bitencourt J, Sarno A, Oliveira C, et al. Comparing cytokine production and clinical response following vaccination with BCG Moreau and BCG Russia strains in a Brazilian infant population. Vaccine. 2021. PMID: 33965255. doi:10.1016/j.vaccine.2021.04.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。